International EXPAND Heart Pivotal Trial

See also
Status	Clinical Trial	Phase
Completed	`NCT02964026` - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients	N/A
Active, not recruiting	`NCT05096299` - OCS Heart EXPAND + CAP Continued Follow-Up
Not yet recruiting	`NCT05025774` - Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Recruiting	`NCT05933083` - MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation	N/A
Completed	`NCT03150095` - Health Coaching to Improve Self-Management in Thoracic Transplant Candidates	N/A
Active, not recruiting	`NCT02554578` - Impact of mHealth in Heart Transplant Management	N/A
Terminated	`NCT03346278` - Text Message Intervention to Improve Cardiac Rehab Participation	N/A
Active, not recruiting	`NCT05741723` - OCS DCD Heart + CAP Continued Follow-Up
Completed	`NCT03831048` - Donors After Circulatory Death Heart Trial	N/A
Completed	`NCT04615182` - Donor After Circulatory Death Heart CAP Trial	N/A
Completed	`NCT02597543` - Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction	Phase 4
Recruiting	`NCT05824364` - Exercise aNd hEArt Transplant	N/A
Enrolling by invitation	`NCT05390411` - Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial	N/A
Recruiting	`NCT04770012` - AERIAL Trial: Antiplatelet Therapy in Heart Transplantation	Phase 3
Terminated	`NCT01769443` - Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation	Phase 2
Completed	`NCT00466804` - Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients	N/A
Recruiting	`NCT06426173` - Effect of Resistance Training in Patients on the Waiting List for Heart Transplant	N/A
Not yet recruiting	`NCT05459181` - HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)	N/A
Terminated	`NCT01485757` - Prospective L-arginine Study	Phase 1
Active, not recruiting	`NCT01186250` - Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation	Phase 2

NCT number	NCT02323321
Study type	Interventional
Source	TransMedics
Contact
Status	Completed
Phase	N/A
Start date	September 16, 2015
Completion date	March 2, 2019

International EXPAND Heart Pivotal Trial — EXPANDHeart

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms